ESCRS - RayOne Trifocal & Sulcoflex Trifocal: Leading the Way to Offer More Patients a Trifocal Solution

RayOne Trifocal & Sulcoflex Trifocal: Leading the Way to Offer More Patients a Trifocal Solution

RayOne Trifocal & Sulcoflex Trifocal: Leading the Way to Offer More Patients a Trifocal Solution
Colin Kerr
Colin Kerr
Published: Friday, February 1, 2019
In this supplement, published by EuroTimes and sponsored by Rayner, leading ophthalmologists discuss their experiences with the Rayner RayOne and Sulcoflex Trifocal lenses, drawing on extensive research to demonstrate their findings. Download Supplement - click here
Latest Articles
Committing to a More Equitable Ophthalmology

Charity Committee enhances ESCRS’s reputation as a socially responsible society.

Read more...

Virtual Community Unites Ukrainian Eye Specialists

Microlearning platform proves vital to saving eyes and lives in areas of conflict.

Read more...

ESCRS Survey Shifts Industry Dial

Annual survey reveals trends and issues regarding the digital OR.

Read more...

Always Measure the Epithelium!

Epithelium thickness mapping key to better refractive outcomes.

Read more...

Brave New World of AI

More applications for anterior segment anticipated.

Read more...

Advancing Vision Research

National Eye Institute initiatives encourage AI-based innovations and data interoperability.

Read more...

Best Candidates for Phakic EDOF IOLs?

Patient profile suggests limits for phakic EDOF approach.

Read more...

Knowing Iris Repair: Iris Repair with Prosthetic Devices

New devices on the market expand available options when iris tissue is insufficient.

Read more...

Targeting the Kallikrein-Kinin System to Treat DME

Novel oral plasma kallikrein inhibitor shows promise in early clinical trial.

Read more...

Faricimab VOYAGER Study

Real-world experience with faricimab for treatment-naïve nAMD and DME is underway.

Read more...